7 September 2023
SHARE NOW
ATE
Scaling Up
Strategy
Pedro Silva Couto leads this session on establishing a scalable non-viral CAR-T manufacturing process using a transposon-transposase system
In this session, Pedro Silva Couto, Postdoctoral Research Fellow, UCL, delivers an insightful presentation on establishing a scalable non-viral CAR-T manufacturing process using a transposon-transposase system.
Following Pedro’s presentation is a Q&A panel with:
- David Sourdive, Executive Vice President CMC & Manufacturing, Cellectis
- Niloofaar Davoodi, Product Operations Lead, Cell Therapy, Takeda
- Amandine Breton, Director MSAT & AST, Orchard Therapeutics
- Elisabet Aguilar, Expert in Quality and Improvement of Advanced Therapies, Andalusian Network for Design Translation of Advanced Therapies
The panel of experts delve into strategies and implementations needed to progress MSAT by exploring development, standards & standardization manufacturing technologies for commercial production.
To watch more videos on the topic of MSAT from Advanced Therapies Europe 2023, watch here >>
This Briefing was recorded at Advanced Therapies Europe 2023.
More like this
Cell and Gene Therapies News Round-Up: October 11
Welcome to Phacilitate’s weekly news round-up, which will bring you the latest advanced therapies news and resources each Friday in the lead up to Advanced Therapies Week 2025 in Dallas. This round-up covers manufacturing, investment, therapeutic development, clinical trials, and any stories making the headlines that week.
11 October 2024
